|View printer-friendly version|
|Array BioPharma to Present at the C.E. Unterberg, Towbin Emerging Growth Conference|
BOULDER, Colo., July 6 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the C.E. Unterberg, Towbin Emerging Growth Conference on July 12 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: C.E. Unterberg, Towbin Emerging Growth Conference
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.